Author

K. Benejova

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. A. Tarhini· 1 shared A. C. Tan· 1 shared A. E. G. Osman· 1 shared A. P. Ikeguchi· 1 shared B. P. Schneider· 1 shared C. Altaner· 1 shared C. E. Wheeler· 1 shared C. H. Chan· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. A. Tarhini

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The tumor microbiome reacts to hypoxia and can influence response to radiation treatment in colorectal cancer

M. Benej, R. Hoyd, M. Kreamer, C. E. Wheeler, D. J. Grencewicz, F. Choueiry, C. H. Chan, Y. Zakharia, Q. Ma, R. D. Dodd, C. M. Ulrich, S. Hardikar, M. L. Churchman, A. A. Tarhini, L. A. Robinson, , D. Spakowicz

The paper examines how hypoxia affects the tumor microbiome and its interaction with radiation response in colorectal cancer using RNA-seq data and experimental models.

bioRxiv · Sep 1, 2023Immunology

Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes

C. Altaner, U. Altanerova, J. Jakubechova, K. Benejova, P. Priscakova, M. Pesta, P. Pitule, O. Topolcan, J. Kausitz, M. Zduriencikova, V. Repiska

This study demonstrates that mesenchymal stem cell exosomes engineered with suicide genes can deliver prodrugs intracellularly to kill tumor cells.

bioRxiv · Mar 13, 2018Cancer Biology